Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause
Public ClinicalTrials.gov record NCT00421031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Efficacy and Safety Study of DVS-233 SR For Relief of Vasomotor Symptoms Associated With Menopause
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy and safety of 4 doses of desvenlafaxine-233 sustained release (DVS-233 SR) as compared to placebo for the treatment of moderate to severe vasomotor symptoms associated with menopause, as well as its influence on sleep parameters and other health outcomes indicators.
Study identification
- NCT ID
- NCT00421031
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 540 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Apr 2004 (Type not available)
- Last update posted
- Jan 11, 2007
2003 – 2004
United States locations
- U.S. sites
- 41
- U.S. states
- 24
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Montgomery | Alabama | 36116 | — |
| Not listed | Peoria | Arizona | 85345 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Stanford | California | 94143 | — |
| Not listed | Colorado Springs | Colorado | 80907 | — |
| Not listed | Newark | Delaware | 19713 | — |
| Not listed | Aventura | Florida | 33160 | — |
| Not listed | Fort Myers | Florida | 33990 | — |
| Not listed | Inverness | Florida | 34452 | — |
| Not listed | Miami | Florida | 33143 | — |
| Not listed | New Port Richey | Florida | 32701 | — |
| Not listed | Ocala | Florida | 34470 | — |
| Not listed | Orange City | Florida | 32763 | — |
| Not listed | Pinellas Park | Florida | 33781 | — |
| Not listed | Tampa | Florida | 33709 | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | West Venice | Florida | 34285 | — |
| Not listed | Atlanta | Georgia | 30342 | — |
| Not listed | Savannah | Georgia | 31405 | — |
| Not listed | Newburgh | Indiana | 47630 | — |
| Not listed | Lexington | Kentucky | 40536 | — |
| Not listed | Shreveport | Louisiana | 71103 | — |
| Not listed | Portland | Maine | 04102 | — |
| Not listed | Chaska | Minnesota | 55387 | — |
| Not listed | Jackson | Mississippi | 39216 | — |
| Not listed | St Louis | Missouri | 63131 | — |
| Not listed | Billings | Montana | 59101 | — |
| Not listed | Las Vegas | Nevada | 89119 | — |
| Not listed | Reno | Nevada | 89509 | — |
| Not listed | Albuquerque | New Mexico | 87102 | — |
| Not listed | Albuquerque | New Mexico | 87131 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Canton | Ohio | 44406 | — |
| Not listed | Cincinnati | Ohio | 45249 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Portland | Oregon | 97201 | — |
| Not listed | Erie | Pennsylvania | 16502 | — |
| Not listed | Wexford | Pennsylvania | 15090 | — |
| Not listed | Greenville | South Carolina | 29605 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00421031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2007 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00421031 live on ClinicalTrials.gov.